Skin-Resident T Cells Drive Dermal Dendritic Cell Migration in Response to Tissue Self-Antigen.
Niwa AliBahar ZirakHong-An TruongMegan M MauranoIris Karina GratzAbul K AbbasMichael D RosenblumPublished in: Journal of immunology (Baltimore, Md. : 1950) (2018)
Migratory dendritic cell (DC) subsets deliver tissue Ags to draining lymph nodes (DLNs) to either initiate or inhibit T cell-mediated immune responses. The signals mediating DC migration in response to tissue self-antigen are largely unknown. Using a mouse model of inducible skin-specific self-antigen expression, we demonstrate that CD103+ dermal DCs (DDCs) rapidly migrate from skin to skin DLN (SDLNs) within the first 48 h after Ag expression. This window of time was characterized by the preferential activation of tissue-resident Ag-specific effector T cells (Teffs), with no concurrent activation of Ag-specific Teffs in SDLNs. Using genetic deletion and adoptive transfer approaches, we show that activation of skin-resident Teffs is required to drive CD103+ DDC migration in response to tissue self-antigen and this Batf3-dependent DC population is necessary to mount a fulminant autoimmune response in skin. Conversely, activation of Ag-specific Teffs in SDLNs played no role in DDC migration. Our studies reveal a crucial role for skin-resident T cell-derived signals, originating at the site of self-antigen expression, to drive DDC migration during the elicitation phase of an autoimmune response.
Keyphrases
- dendritic cells
- wound healing
- soft tissue
- immune response
- poor prognosis
- patient safety
- lymph node
- mouse model
- quantum dots
- quality improvement
- squamous cell carcinoma
- early stage
- gene expression
- radiation therapy
- toll like receptor
- highly efficient
- neoadjuvant chemotherapy
- single cell
- locally advanced
- dna methylation
- rectal cancer
- type iii
- case control